Showing results (2641-2650 of 3,088) with videos related to

Sort By:
Pageof 309
Drug Safety|December 15, 2010
Uterine perforation with the levonorgestrel-releasing intrauterine device: analysis of reports from four national pharmacovigilance centresKees van Grootheest, Bernhardt Sachs, Mira Harrison-Woolrych, et al.
Drug Safety|December 15, 2010
New postgraduate qualifications in pharmacovigilance from the Drug Safety Research Unit in the UKElizabeth Lynn, Deborah Layton, Saad Shakir
Drug Safety|February 22, 2011
Parental reporting of adverse drug reactions associated with attention-deficit hyperactivity disorder (ADHD) medications in children attending specialist paediatric clinics in the UKMansour Tobaiqy, Derek Stewart, Peter J Helms, et al.
Drug Safety|January 1, 1990
The toxicity of cytarabineJ Stentoft
Drug Safety|November 1, 1991
Drug-induced orthostatic hypotensionJ A Schoenberger
Drug Safety|November 1, 1991
Drug-related lupus. Incidence, mechanisms and clinical implicationsL E Adams, E V Hess
Drug Safety|November 1, 1991
Adverse drug reactions leading to hospital admissionL Ibáñez, J R Laporte, X Carné
Drug Safety|November 2, 2007
Drug-induced skin, nail and hair disordersLaurence Valeyrie-Allanore, Bruno Sassolas, Jean-Claude Roujeau
Drug Safety|August 19, 2007
Gold standards in pharmacovigilance: the use of definitive anecdotal reports of adverse drug reactions as pure gold and high-grade oreManfred Hauben, Jeffrey K Aronson
Drug Safety|August 19, 2007
Physician response to patient reports of adverse drug effects: implications for patient-targeted adverse effect surveillanceBeatrice A Golomb, John J McGraw, Marcella A Evans, et al.
Pageof 309